BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10994550)

  • 21. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotrophins and Trk receptors in primitive neuroectodermal tumor cell lines.
    Chiappa SA; Chin LS; Zurawel RH; Raffel C
    Neurosurgery; 1999 Nov; 45(5):1148-54; discussion 1154-5. PubMed ID: 10549931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High microvessel density in primitive neuroectodermal brain tumors of childhood.
    Grotzer MA; Wiewrodt R; Janss AJ; Zhao H; Cnaan A; Sutton LN; Rorke LB; Phillips PC
    Neuropediatrics; 2001 Apr; 32(2):75-9. PubMed ID: 11414647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
    Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
    Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
    Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
    Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autocrine regulation of nerve growth factor expression by Trk receptors.
    Mallei A; Rabin SJ; Mocchetti I
    J Neurochem; 2004 Sep; 90(5):1085-93. PubMed ID: 15312164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.
    Bakish J; Hargrave D; Tariq N; Laperriere N; Rutka JT; Bouffet E
    Cancer; 2003 Sep; 98(5):1014-20. PubMed ID: 12942570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of trkB and trkC receptors and their ligands brain-derived neurotrophic factor and neurotrophin-3 in the murine amygdala.
    Krause S; Schindowski K; Zechel S; von Bohlen und Halbach O
    J Neurosci Res; 2008 Feb; 86(2):411-21. PubMed ID: 17828769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
    von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
    Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
    Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
    Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
    Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
    Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
    de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
    J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.
    Weickert CS; Ligons DL; Romanczyk T; Ungaro G; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
    Mol Psychiatry; 2005 Jul; 10(7):637-50. PubMed ID: 15940304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative mRNA expression analysis of neurotrophin-receptor TrkC and oncogene c-MYC from formalin-fixed, paraffin-embedded primitive neuroectodermal tumor samples.
    Kunz F; Shalaby T; Lang D; von Büren A; Hainfellner JA; Slavc I; Tabatabai G; Grotzer MA
    Neuropathology; 2006 Oct; 26(5):393-9. PubMed ID: 17080715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor.
    Eggert A; Grotzer MA; Ikegaki N; Zhao H; Cnaan A; Brodeur GM; Evans AE
    J Clin Oncol; 2001 Feb; 19(3):689-96. PubMed ID: 11157019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.
    Segal RA; Goumnerova LC; Kwon YK; Stiles CD; Pomeroy SL
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12867-71. PubMed ID: 7809137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents.
    Fangusaro J; Massimino M; Rutkowski S; Gururangan S
    Pediatr Blood Cancer; 2010 Apr; 54(4):638-40. PubMed ID: 20146218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.
    Huber H; Eggert A; Janss AJ; Wiewrodt R; Zhao H; Sutton LN; Rorke LB; Phillips PC; Grotzer MA
    Eur J Cancer; 2001 Nov; 37(16):2064-72. PubMed ID: 11597385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.